2021
The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics
DLOUHA, Lucie, Terezie PELIKANOVA, Jiri VELEBA, Vera ADAMKOVA, Vera LANSKA et. al.Základní údaje
Originální název
The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics
Autoři
DLOUHA, Lucie (203 Česká republika), Terezie PELIKANOVA (203 Česká republika), Jiri VELEBA (203 Česká republika), Vera ADAMKOVA (203 Česká republika), Vera LANSKA (203 Česká republika), Tomas SOSNA (203 Česká republika), Lukáš PÁCAL (203 Česká republika, domácí), Kateřina KAŇKOVÁ (203 Česká republika, domácí) a Jaroslav A. HUBACEK (203 Česká republika, garant)
Vydání
MOLECULAR BIOLOGY REPORTS, DORDRECHT, Springer, 2021, 0301-4851
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
10608 Biochemistry and molecular biology
Stát vydavatele
Nizozemské království
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.742
Kód RIV
RIV/00216224:14110/21:00120128
Organizační jednotka
Lékařská fakulta
UT WoS
000679622300004
Klíčová slova anglicky
Retinopathy; T2DM; Apolipoprotein E; Polymorphism; Gender
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 18. 1. 2022 14:43, Mgr. Tereza Miškechová
Anotace
V originále
Background Common polymorphisms within the apolipoprotein E (APOE) gene are suggested to be associated with the development of type 2 diabetes mellitus (T2DM), but the potential association with T2DM complications (nephropathy, neuropathy and retinopathy) remains unclear. We perform the case-control study to analyse the association between the APOE polymorphism and risk of T2DM and to analysed the potential relationship between the APOE and T2DM complications. Methods and results APOE variants (rs429358 and rs7412) were genotyped by TaqMan assay in T2DM patients (N = 1274; N = 829 with complications including retinopathy, neuropathy and nephropathy status) and with PCR-RFLP in healthy nondiabetic controls (N = 2055). The comparison of subjects with genotypes associated with low plasma cholesterol (APOE2/E2 and APOE2/E3 carriers vs. others) did not show an association with T2DM (OR [95% CI] = 0.88 [0.71-1.08). The differences remained insignificant after adjusting for diabetes duration, sex and BMI. Carriers of at least one APOE4 allele (rs429358) are protected against T2DM related retinopathy (OR [95% CI] = 0.65 [0.42-0.99]. Protection against retinopathy is driven mostly by females (OR [95% CI] = 0.50 [0.25-0.99]); and remains significant (P = 0.044) after adjustment for diabetes duration and BMI. Conclusion Common APOE polymorphism was not associated with T2DM in the Czech population. Yet, APOE4 allele revealed an association with retinopathy. In particular, female T2DM patients with at least one APOE4 allele exhibit lower prevalence of retinopathy in our study subjects.
Návaznosti
NV18-01-00046, projekt VaV |
|